The global healthcare industry is undergoing a paradigm shift as gene and cell therapies increasingly move from experimental research into commercialized treatment options. At the core of this transition is the viral vector & plasmid DNA manufacturing market, which provides the essential biological materials required to develop advanced therapeutics and vaccines. The demand for these...
English
Kiswahili
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek
